glp-1 compounding crackdown news october 2025 National Hispanic Medical Association | The federal government is stepping up to stop counterfeit weight-loss drugs. In 2025, bipartisan lawmakers urged stronger FDA enforcement Troubling Findings in Study of

En sujetos obesos, estos cambios determinan la reduccin del gasto de energa y la recuperacin de peso, asociados con la acumulacin de lpidos

Abbreviations AEs: Adverse events NAEs: Neurological adverse events FDA: The Food and Drug Administration FAERS: The FDA Adverse Event Reporting System GLP-1 RAs: Glucagon-like peptide-1 receptor agonists ADRs: Adverse drug reactions PTs: Preferred Terms SOCs: System Organ Classes IQR: Interquartile range ROR: Reporting odds ratio CI: Confidence interval PRR: Proportional reporting ratio BCPNN: Bayesian Confidence Propagation Neural Network EBGM: Empirical Bayesian geometric mean EBGM05: The lower limit of 95% CI of EBGM IC: Information component IC025: The lower limit of 95% CI of the IC VANs: Vagal afferent neurons T2DM: Type 2 diabetes mellitus OR: Odds ratios References Targher, G., Mantovani, A

Cosmetics (Basel)

An investigation by the Houston Chronicle found that state and federal oversight efforts are murky with compounding pharmacies because they dont have to disclose reports of patient harm

Protein prioritization protocol Make protein the non-negotiable foundation of every meal

Gao Y, Peterson E, Pagidipati N